Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02818972 · ClinicalTrials.gov registry record · NA
RelayPro Thoracic Stent-Graft in Subjects With Thoracic Aortic Aneurysms and Penetrating Atherosclerotic Ulcers
A NA study of Aortic Aneurysm, Thoracic and Penetrating Ulcer, sponsored by Bolton Medical.
- Active
- Registry status
- NA
- Development phase
- 110
- Enrollment target
- 20
- Study locations
NCT02818972: Active NA study of Aortic Aneurysm, Thoracic and Penetrating Ulcer, sponsored by Bolton Medical.
NCT02818972 is a NA study of Aortic Aneurysm, Thoracic and Penetrating Ulcer that is active but no longer recruiting, run by Bolton Medical. The registered enrollment target is 110 participants, below the 218-participant average among 4 other Aortic Aneurysm, Thoracic trials with a reported enrollment target (50% lower). The trial reports 20 study locations across 14 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02818972, a NA study of Aortic Aneurysm, Thoracic and Penetrating Ulcer, is active but no longer recruiting, sponsored by Bolton Medical.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
- 20
- Study locations
Study Summary
Investigate the safety and effectiveness of the RelayPro Thoracic Stent-Grafts in subjects with thoracic aortic aneurysms (TAA) and penetrating atherosclerotic ulcers (PAU) of the descending thoracic aorta.
Primary Outcome
Primary safety endpoint is a composite of the following MAEs occurring through 30 days: * Death * Stroke (excluding transient ischemic attack) * Paralysis (excludes paraparesis)
Conditions Studied
Interventions
- DEVICE RelayPro
Study Locations (20)
Massachusetts
- Tufts Medical Center - Boston
- Beth Israel Deaconess Medical Center / Harvard Medical School - Boston
- Baystate Medical Center - Springfield
California
- University of California, Irvine - Irvine
- Long Beach Memorial Hospital - Long Beach
Indiana
- Indiana University Health - Indianapolis
- St. Vincent Heart Center - Indianapolis
Ohio
- University Hospitals - Cleveland
- Cleveland Clinic Foundation - Cleveland
Pennsylvania
- University of Pennsylvania Medical Center / Penn Presbyterian - Philadelphia
- Lankenau Medical Center - Wynnewood
Alabama
- University of Alabama-Birmingham - Birmingham
Arizona
- Arizona Heart Institute - Phoenix
Connecticut
- Hartford Hospital - Hartford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2017-05-10 |
| Est. Completion | 2025-12 |
| Phase | NA |
What the registry record for NCT02818972 still lists
NCT02818972 is an interventional study that assigns participants to a tested intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap, below the 218-participant average among 4 other Aortic Aneurysm, Thoracic trials with a reported enrollment target (50% lower).
The record links to 2 conditions, with Aortic Aneurysm, Thoracic appearing as the primary indexed condition, and to 1 intervention - of which RelayPro is the first listed.
NCT02818972 names 20 study sites across 14 states, led by Massachusetts, California, Indiana.
Frequently Asked Questions
What is clinical trial NCT02818972 about?
NCT02818972 is a clinical study titled "RelayPro Thoracic Stent-Graft in Subjects With Thoracic Aortic Aneurysms and Penetrating Atherosclerotic Ulcers". Investigate the safety and effectiveness of the RelayPro Thoracic Stent-Grafts in subjects with thoracic aortic aneurysms (TAA) and penetrating atherosclerotic ulcers (PAU) of the descending thoracic aorta.
What is the current status of trial NCT02818972?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 110 participants. The study started on 2017-05-10. Estimated completion is 2025-12.
What conditions does trial NCT02818972 study?
This clinical trial studies the following conditions: Aortic Aneurysm, Thoracic, Penetrating Ulcer.
What interventions are being tested in trial NCT02818972?
The interventions under investigation include: RelayPro (DEVICE).
Who is sponsoring clinical trial NCT02818972?
This trial is sponsored by Bolton Medical, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02818972 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Connecticut, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aortic Aneurysm, Thoracic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Endovascular Treatment of TAAA and Aortic Arch Aneurysms Using Fenestrated and Branched Stent Grafts
RECRUITING · NA
-
Evaluation of the GORE® TBE Device in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 2
ACTIVE NOT RECRUITING · NA
-
Evaluation of the GORE® TBE Device in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 0/1
ACTIVE NOT RECRUITING · NA
-
GORE TAG® Thoracic Endoprosthesis - 45 mm for the Treatment of Aneurysms of the Descending Thoracic Aorta
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI